NCT06494033View on ClinicalTrials.gov

Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients

RecruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

December 3, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Lung Diseases

Trial Locations (1)

33136

RECRUITING

University of Miami, Miami

All Listed Sponsors

collaborator

Eurofins Viracor, LLC

UNKNOWN

lead

University of Miami

OTHER